Hormone-Refractory Prostate Cancer Completed Phase 3 Trials for Sipuleucel-T (DB06688)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01133704Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate CancerTreatment